Tripar Multivision Plus Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Tripar Multivision Plus Tbk. trades at Rp176 (market cap 1.23T, 1.26M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 10× Tripar Multivision Plus Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.41M versus 1.26M). Which is the better fit depends on your goals.
| RAAM | TSPC | |
|---|---|---|
Market Cap | 1.23T | 12.36T |
Volume | 1.26M | 1.41M |
Lot | 12.56K | 14.08K |
Turnover | 222.66M | 3.83B |
Average Price | 177.28 | 2,722.04 |
Value | 222.66M | 3.83B |
Indicative Equilibrium Price | 176 | 2,730 |
Indicative Equilibrium Volume | 1.39K | 2.51K |
Trailing returns across standard periods
Latest headlines on both assets
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →